Operon Strategist at Inventicon

Operon Strategist at Inventicon 2025: Insights on Evolving Medical Device Regulations

It was a real pleasure to be part of Inventicon, held at Pride Plaza, Delhi, on 21st and 22nd August 2025. The event brought together leaders from the medical device regulatory domain, creating a strong platform for discussions on compliance, quality, and patient safety.

Contact Us

Panel Discussion on Evolving Device Regulations

I had the opportunity to be part of a panel discussion on:
“Evolving device regulations- Ensuring compliance, quality and patient safety.”

The discussion covered key themes such as:

  • Essential principles of safety and effectiveness for medical devices and the role of standards
  • Tools and strategies for quality improvement and patient safety
  • Measures and benchmarks to achieve desired outcomes

    Moderator

    • Mr. Parveen Jain, RAC (Devices), Senior Director, Quality and Regulatory Affairs Asia Pacific, Fresenius Medical Care


    Panellists

    • Mr. Bivash Chakraborty, Head – Regulatory Affairs & Quality & Public Business – India & South Asia, Biomerieux India Pvt. Ltd.
    • Mr. Anil Chaudhari, Founder and CEO, Operon Strategist
    • Ms. Jhankhana Gyani, Head – QRA, Draeger India
    • Mr. Alok Kumar Soni, Head – Regulatory Affairs & Quality Assurance, India & South Asia, Bio-Rad Laboratories (India) Pvt. Ltd.

    Also Read: PPE storage solutions for safety.

Key Takeaways from the Session

The session was attended by over 150 delegates from the regulatory domain, making the discussion highly engaging and impactful.

One of the important points I emphasized was the way gaps between design and manufacturing processes can sometimes weaken the product development chain. Such gaps may affect product efficacy and safety, leading to customer complaints or even product failures. Addressing these challenges through a strong regulatory framework and effective quality strategies is essential for achieving safe and reliable medical devices.

The session was well navigated by Mr. Parveen, and each panellist contributed meaningful perspectives that ensured attendees left with clear takeaways on navigating evolving regulations.

A Truly Enriching Experience

Inventicon 2025 was not just an event but an excellent opportunity to exchange knowledge, connect with industry experts, and reflect on how the medical device ecosystem can evolve with changing regulations.

At Operon Strategist, we remain committed to supporting manufacturers and startups in achieving compliance while ensuring quality and patient safety remain at the center of every decision.

Also Read: CDSCO MD-26 & MD-27: New Medical Device Approval in India.

Consult Operon Strategist’s regulatory specialists today to streamline your compliance roadmap

Accelerate Market Access with End-to-End Regulatory Guidance

Strategic MedTech Consulting: How Operon Strategist Supports Your Compliance Journey

As demonstrated during industry forums like Inventicon, Operon Strategist provides end-to-end consulting services to help medical device manufacturers achieve regulatory compliance, maintain quality standards, and accelerate market access:

  • Quality Management System (QMS) Implementation: Custom drafting and deployment of SOPs, Quality Manuals, and audit-ready frameworks via our dedicated QMS Consulting Services.

  • Global Product Registration & Clearance: Strategic preparation and filing of technical dossiers for US FDA 510(k), EU MDR CE Marking, CDSCO India, and global markets through our Global Registration Services.

  • Turnkey Facility Setup & Manufacturing Engineering: Cleanroom layout design, process engineering, and plant validation.

  • Design Transfer & Risk Management (ISO 14971): Bridging design and manufacturing gaps through systematic risk assessments, process validation (IQ/OQ/PQ), and Design History File (DHF) compilation.

  • Audit Representation & Regulatory Defense: Hands-on technical support during Notified Body audits, CDSCO inspections, and US FDA compliance reviews.

Need expert guidance for QMS setup

Connect with Operon Strategist’s consulting team today

FAQ's

Operon Strategist participated in an expert panel addressing evolving medical device regulations, strategies for bridging design-to-manufacturing gaps, and methods for ensuring quality and patient safety.

Gaps between initial design specifications and actual manufacturing processes can lead to product inconsistencies, safety risks, post-market customer complaints, or costly product recalls.

Medical devices in India are regulated by the Central Drugs Standard Control Organization (CDSCO) under the Medical Devices Rules (MDR) 2017, requiring specific manufacturing and import licenses (e.g., MD-26, MD-27).

A compliant QMS (such as ISO 13485) ensures that manufacturing and design processes remain controlled, traceable, and compliant with international regulatory standards.

Operon Strategist offers turnkey consulting for facility setup, ISO 13485 QMS implementation, technical documentation, design transfer validation, and global product registrations.